Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells

Journal of Neuroscience Research

Volumn 83, Issue 8, 2006, Pages 1591-1600

  Kuhla, Björn ^a,b   Lüth, Hans Joachim ^c   Haferburg, Dietrich ^d   Weick, Michael ^c   Reichenbach, Andreas ^c   Arendt, Thomas ^c   Münch, Gerald ^a,e  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c Paul Flechsig Inst for Brain Res   (Germany)

^d Institute of Biochemistry   (Germany)

^e JAMES COOK UNIVERSITY   (Australia)

Author keywords

Alzheimer's disease; Calcium; Caspase 3; Glyoxalase I; Methylglyoxal; Okadaic acid; Oxidative stress; Protein phosphatases; Tau phosphorylation

Indexed keywords

EPITOPE; GLYOXALASE; LACTOYLGLUTATHIONE LYASE; METHYLGLYOXAL; OKADAIC ACID; SERINE; STRESS ACTIVATED PROTEIN KINASE; TAU PROTEIN; THREONINE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEPHOSPHORYLATION; DRUG EFFECT; DRUG INHIBITION; MOUSE; NERVE DEGENERATION; NEUROBLASTOMA CELL; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; STAINING; WESTERN BLOTTING;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN; CASPASE 3; CASPASES; CELL LINE, TUMOR; DOWN-REGULATION; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; LACTOYLGLUTATHIONE LYASE; NERVE DEGENERATION; NEURITES; NEUROBLASTOMA; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PYRUVALDEHYDE; TAU PROTEINS; TIME FACTORS;

EID: 33744903657     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20838     Document Type: Article

References (59)

1. Adamec E, Mercken M, Beermann ML, Didier M, Nixon RA. 1997. Acute rise in the concentration of free cytoplasmic calcium leads to dephosphorylation of the microtubule-associated protein tau. Brain Res 757:93-101.
2. Akhand AA, Hossain K, Mitsui H, Kato M, Miyata T, Inagi R, Du J, Takeda K, Kawamoto Y, Suzuki H, Kurokawa K, Nakashima I. 2001. Glyoxal and methylglyoxal trigger distinct signals for map family kinases and caspase activation in human endothelial cells. Free Radic Biol Med 31:20-30.
3. Amicarelli F, Colafarina S, Cattani F, Cimini A, Di Ilio C, Ceru MP, Miranda M. 2003. Scavenging system efficiency is crucial for cell resistance to ROS-mediated methylglyoxal injury. Free Radic Biol Med 35: 856-871.
4. Brenner M, Huber W. 1953. Herstellung von alpha-Aminosäureestern durch Alkoholyse der Methylester. Helv Chim Acta 36:1109-1115.
5. Calingasan NY, Uchida K, Gibson GE. 1999. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J Neurochem 72:751-756.
6. Chang KC, Paek KS, Kim HJ, Lee YS, Yabe-Nishimura C, Seo HG. 2002. Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes. Mol Pharmacol 61:1184-1191.
7. Cook LJ, Davies J, Yates AP, Elliott AC, Lovell J, Joule JA, Pemberton P, Thornalley PJ, Best L. 1998. Effects of methylglyoxal on rat pancreatic beta-cells. Biochem Pharmacol 55:1361-1367.
8. David DC, Layfield R, Serpell L, Narain Y, Goedert M, Spillantini MG. 2002. Proteasomal degradation of tau protein. J Neurochem 83:176-185.
9. Davis DR, Anderton BH, Brion JP, Reynolds CH, Hanger DP. 1997. Oxidative stress induces dephosphorylation of tau in rat brain primary neuronal cultures. J Neurochem 68:1590-1597.
10. Du J, Suzuki H, Nagase F, Akhand AA, Yokoyama T, Miyata T, Kurokawa K, Nakashima I. 2000. Methylglyoxal induces apoptosis in Jurkat leukemia T cells by activating c-Jun N-terminal kinase. J Cell Biochem 77:333-344.
11. Ekinci FJ, Shea TB. 1999. Hyperactivation of mitogen-activated protein kinase increases phospho-tau immunoreactivity within human neuroblastoma: additive and synergistic influence of alteration of additional kinase activities. Cell Mol Neurobiol 19:249-260.
12. Fukunaga M, Miyata S, Liu BF, Miyazaki H, Hirota Y, Higo S, Hamada Y, Ueyama S, Kasuga M. 2004. Methylglyoxal induces apoptosis through activation of p38 MAPK in rat Schwann cells. Biochem Biophys Res Commun 320:689-695.
13. Gastard MC, Troncoso JC, Koliatsos VE. 2003. Caspase activation in the limbic cortex of subjects with early Alzheimer's disease. Ann Neurol 54:393-398.
14. Goedert M, Jakes R, Qi Z, Wang JH, Cohen P. 1995. Protein phosphatase 2A is the major enzyme in brain that dephosphorylates tau protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase. J Neurochem 65:2804-2807.
15. Goedert M, Hasegawa M, Jakes R, Lawler S, Cuenda A, Cohen P. 1997. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett 409:57-62.
16. Goldbaum O, Richter-Landsberg C. 2002. Activation of PP2A-like phosphatase and modulation of tau phosphorylation accompany stress-induced apoptosis in cultured oligodendrocytes. Glia 40:271-282.
17. Gomez-Ramos A, Diaz-Nido J, Smith MA, Perry G, Avila J. 2003. Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells. J Neurosci Res 71:8638-8670.
18. Gong CX, Grundke-Iqbal I, Iqbal K. 1994. Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A. Neuroscience 61:765-772.
19. Haik GM Jr, Lo TW, Thornalley PJ. 1994. Methylglyoxal concentration and glyoxalase activities in the human lens. Exp Eye Res 59:497-500.
20. Han LP, Davison LM, Vander Jagt DL. 1976. Purification and kinetic study of glyoxalase-I from rat liver, erythrocytes, brain and kidney. Biochim Biophys Acta 445:486-499.
21. Ho DT, Shayan H, Murphy TH. 1997. Okadaic acid induces hyperphosphorylation of tau independently of mitogen-activated protein kinase activation. J Neurochem 68:106-111.
22. Kern JC, Kehrer JP. 2002. Acrolein-induced cell death: a caspase-influenced decision between apoptosis and oncosis/necrosis. Chem Biol Interact 139:79-95.
23. Kikuchi S, Shinpo K, Moriwaka F, Makita Z, Miyata T, Tashiro K. 1999. Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical neurons: synergism between glycation and oxidative stress, possibly involved in neurodegenerative diseases. J Neurosci Res 57:280-289.
24. Ko LW, Ko EC, Nacharaju P, Liu WK, Chang E, Kenessey A, Yen SH. 1999. An immunochemical study on tau glycation in paired helical filaments. Brain Res 830:301-313.
25. Krishnamurthy PK, Mays JL, Bijur GN, Johnson GV. 2000. Transient oxidative stress in SH-SY5Y human neuroblastoma cells results in caspase dependent and independent cell death and tau proteolysis. J Neurosci Res 61:515-523.
26. Kuhla B, Boeck K, Lüth H-J, Schmidt A, Weigle B, Schmitz M, Ogunlade V, Munch G, Arendt T. 2006. Age-dependent changes of glyoxalase I expression in human brain. Neurobiol Aging (in press).
27. Lapolla A, Flamini R, Dalla Vedova A, Senesi A, Reitano R, Fedele D, Basso E, Seraglia R, Traldi P. 2003. Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method. Clin Chem Lab Med 41:1166-1173.
28. Lee CW, Lau KF, Miller CC, Shaw PC. 2003. Glycogen synthase kinase-3 beta-mediated tau phosphorylation in cultured cell lines. Neuroreport 14:257-260.
29. Liu BF, Miyata S, Hirota Y, Higo S, Miyazaki H, Fukunaga M, Hamada Y, Ueyama S, Muramoto O, Uriuhara A, Kasuga M. 2003a. Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells. Kidney Int 63:947-957.
30. Liu W, Akhand AA, Takeda K, Kawamoto Y, Itoigawa M, Kato M, Suzuki H, Ishikawa N, Nakashima I. 2003b. Protein phosphatase 2A-linked and -unlinked caspase-dependent pathways for down-regulation of Akt kinase triggered by 4-hydroxynonenal. Cell Death Differ 10: 727-781.
31. Lo TW, Thornalley PJ. 1992. Inhibition of proliferation of human leukaemia 60 cells by diethyl esters of glyoxalase inhibitors in vitro. Biochem Pharmacol 44:2357-2363.
32. Lorio G, Avila J, Diaz-Nido J. 2001. Modifications of tau protein during neuronal cell death. J Alzheimers Dis 3:563-575.
33. Lovell MA, Xie C, Markesbery WR. 2001. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 22:187-194.
34. Luo Y, Ingram VM. 2001. Uncoupling of mitochondria activates protein phosphatases and inactivates MBP protein kinases. J Alzheimers Dis 3:593-598.
35. Mattson MP, Fu W, Waeg G, Uchida K. 1997. 4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau. Neuroreport 8:2275-2281.
36. McLellan AC, Thornalley PJ. 1989. Glyoxalase activity in human red blood cells fractioned by age. Mech Ageing Dev 48:63-71.
37. Mills JC, Lee VM, Pittman RN. 1998. Activation of a PP2A-like phosphatase and dephosphorylation of tau protein characterize onset of the execution phase of apoptosis. J Cell Sci 111:625-636.
38. Miyata T, Kurokawa K, Van Ypersele De Strihou C. 2000. Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J Am Soc Nephrol 11:1744-1752.
39. Norman SG, Johnson GV. 1994. Compromised mitochondrial function results in dephosphorylation of tau through a calcium-dependent process in rat brain cerebral cortical slices. Neurochem Res 19:1151-1158.
40. Odani H, Shinzato T, Matsumoto Y, Usami J, Maeda K. 1999. Increase in three alpha, beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction. Biochem Biophys Res Commun 256:89-93.
41. Okado A, Kawasaki Y, Hasuike Y, Takahashi M, Teshima T, Fujii J, Taniguchi N. 1996. Induction of apoptotic cell death by methylglyoxal and 3-deoxyglucosone in macrophage-derived cell lines. Biochem Biophys Res Commun 225:219-224.
42. Perez M, Hernandez F, Gomez-Ramos A, Smith M, Perry G, Avila J. 2002. Formation of aberrant phosphotau fibrillar polymers in neural cultured cells. Eur J Biochem 269:1484-1489.
43. Rametti A, Esclaire F, Yardin C, Terro F. 2004. Linking alterations in tau phosphorylation and cleavage during neuronal apoptosis. J Biol Chem 279:54518-54528.
44. Reynolds CH, Nebreda AR, Gibb GM, Utton MA, Anderton BH. 1997. Reactivating kinase/p38 phosphorylates tau protein in vitro. J Neurochem 69:191-198.
45. Saito T, Ishiguro K, Uchida T, Miyamoto E, Kishimoto T, Hisanaga S. 1995. In situ dephosphorylation of tau by protein phosphatase 2A and 2B in fetal rat primary cultured neurons. FEBS Lett 376:238-242.
46. Sakamoto H, Mashima T, Sato S, Hashimoto Y, Yamori T, Tsuruo T. 2001. Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressmg human lung cancer cells. Clin Cancer Res 7:2513-2518.
47. Santoro MF, Annand RR, Robertson MM, Peng YW, Brady MJ, Mankovich JA, Hackett MC, Ghayur T, Walter G, Wong WW, Giegel DA. 1998. Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis. J Biol Chem 273:13119-13128.
48. Sharma-Luthra R, Kale RK. 1994. Age related changes in the activity of the glyoxalase system. Mech Ageing Dev 73:39-45.
49. Shea TB, Ekinci FJ. 1999. Biphasic effect of calcium influx on tau phosphorylation: involvement of calcium-dependent phosphatase and kinase activities. J Alzheimers Dis 1:353-360.
50. Smith MA, Sayre LM, Anderson VE, Harris PL, Beal MF, Kowall N, Perry G. 1998. Cytochemical demontration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2, 4- dinitrophenylhydrazine. J Histochem Cytochem 46:731-735.
51. Sommer D, Coleman S, Swanson SA, Stemmer PM. 2002. Differential susceptibilities of serine/threonine phosphatases to oxidative and nitrosative stress. Arch Biochem Biophys 404:271-278.
52. Thornalley PJ, Edwards LG, Kang Y, Wyatt C, Davies N, Ladan MJ, Double J. 1996. Antitumour activity of S-p-bromobenzylglutathione cyclopentyl diester in vitro and in vivo. Inhibition of glyoxalase I and induction of apoptosis. Biochem Pharmacol 51:1365-1372.
53. Thornalley PJ, Jahan I, Ng R. 2001. Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro. J Biochem (Tokyo) 129:543-549.
54. Tian Q, Wang J. 2002. Review. Role of serine/threonine protein phosphatase in Alzheimer's disease. Neurosignals 11:262-269.
55. Tsujio I, Tanaka T, Kudo T, Nishikawa T, Shinozaki K, Grundke-Iqbal I, Iqbal K, Takeda M. 2000. Inactivation of glycogen synthase kinase-3 by protein kinase C delta: implications for regulation of tau phosphorylation. FEBS Lett 469:111-117.
56. Vince R, Daluge S, Wadd WB. 1971. Studies on the inhibition of glyoxalase I by S-substituted glutathiones. J Med Chem 5:402-404.
57. Wei Q, Holzer M, Brueckner MK, Liu Y, Arendt T. 2002. Dephosphorylation of tau protein by calcineurin triturated into neural living cells. Cell Mol Neurobiol 22:13-24.
58. Wondrak GT, Cervantes-Laurean D, Roberts MJ, Qasem JG, Kim M, Jacobson EL, Jacobson MK. 2002. Identification of alpha-dicarbonyl scavengers for cellular protection against carbonyl stress. Biochem Pharmacol 63:361-373.
59. Xie HQ, Johnson GV. 1998. Calcineurin inhibition prevents calpain-mediated proteolysis of tau in differentiated PC12 cells. J Neurosci Res 53:153-164.